Tectonic Therapeutic (TECX) Accumulated Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has reported Accumulated Expenses for 10 consecutive years, with $9.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses rose 82.86% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (up 82.86% YoY), while the FY2025 annual figure was $7.3 million, down 6.5% from the prior year.
• Accumulated Expenses grew to $9.0 million in Q1 2026 per TECX's latest filing, from $7.3 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $20.0 million in Q2 2024 and bottomed at $2.4 million in Q3 2023.
• Historically, Accumulated Expenses has averaged $8.2 million across 5 years, with a median of $7.3 million in 2025.
• On a YoY basis, Accumulated Expenses climbed as much as 441.81% in 2024 and fell as far as 72.25% in 2024.
• Tectonic Therapeutic's Accumulated Expenses stood at $11.7 million in 2022, then tumbled by 30.61% to $8.1 million in 2023, then fell by 3.57% to $7.8 million in 2024, then fell by 6.5% to $7.3 million in 2025, then increased by 22.25% to $9.0 million in 2026.
• Business Quant data shows TECX's Accumulated Expenses at $9.0 million in Q1 2026, $7.3 million in Q4 2025, and $6.8 million in Q3 2025.